Form 4: Cardiff Oncology Director Buys Shares
Insider Transaction (Form 4)
Gary W Pace, a Director of Cardiff Oncology, Inc., purchased 1,374,570 shares of common stock on July 14, 2026 for $1.46 per share.
Summary
- Open-market purchase: acquired 687,285 Common Stock at $1.46 ($1,000,000) on July 14, 2026; holds 2,043,661 after (Direct).
- Open-market purchase: acquired 687,285 Common Stock Purchase Warrant on July 14, 2026; holds 687,285 after (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,000,000, committing personal capital to the stock.
Insider Transactions
Gary W Pace — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Open-market purchase | Common Stock | 687,285 | $1 | $1000.0K | 2,043,661 |
| 2026-07-14 | Open-market purchase | Common Stock Purchase Warrant | 687,285 | — | — | 687,285 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Open-market purchase (687,285 shares) |
| 2026-07-14 | Open-market purchase (687,285 shares) |
Keywords
insider transaction, Form 4, CRDF, Cardiff Oncology, Inc., bullish, Gary W Pace
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.